Micronized Palmitoylethanolamide, Hempseed Oil, and Maritime Pine Bark Dry Extract (Pelvipea®) for Pelvic Pain: An In Vitro Study for Urothelial Inflammation Treatment
article
OA: gold
CC0
AI-generated summary
This in vitro study found that a mixture of micronized PEA, hempseed oil, and maritime pine bark dry extract significantly reduced urothelial inflammation markers compared to individual ingredients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Urothelial inflammation plays a key role in the pathogenesis of chronic pelvic pain due to its origin in the bladder. The aim of this study was to evaluate the efficacy of a patent-pending formulation (Pelvipea®) composed of micronized palmitoylethanolamide (PEA), hempseed oil, and maritime pine bark dry extract in reducing urothelial inflammation, as well as the effect of each ingredient individually, in order to define the synergistic effect of the three ingredients. An in vitro bladder urothelium model composed of the T24 cell line was exposed to a conditioned media obtained by treating macrophage-differentiated THP-1 cells with different concentrations of the functional ingredients and a mixture of them in the presence of the pro-inflammatory stimulus of Escherichia coli. Cells exposed only to the inflammatory stimulus in the absence of pre-treatment were considered as a positive control for inflammation. The impact of each functional ingredient and their mixture on inflammation was evaluated by the determination of transcription factor NF-kB and of pro-inflammatory cytokine expression. Statistical analysis was performed using the t-test, comparing the mixture and the single ingredients for every condition tested. All results were reported as fold change (mean ± standard deviation), the ratio between the values obtained from the respective treatments for inflammation control. The three functional ingredients did not induce negative effects on THP-1 cell vitality. The levels of NF-kB were reduced following treatment with hempseed oil, maritime pine bark dry extract, and the mixture at all tested concentrations, and with micronized PEA from 25 to 200 μg/mL. Treatment with the mixture resulted in the lowest expression levels of interleukins (IL)-1β, IL-6, and IL-8 compared to the single functional ingredients at a concentration of 230 μg/mL, with values of 0.08 (±0.00), 0.01 (±0.00), and 0.32 (±0.01), respectively. The mixture of micronized PEA, hempseed oil, and maritime pine bark dry extract (Pelvipea®) at 230 μg/mL showed the best efficacy in urothelial IL-1β, IL-6, and IL-8 reduction compared with the singular components. This formulation may represent a promising therapeutic option to relieve painful symptoms originating in the bladder. However, in vivo studies are needed to confirm these results.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (33)
- Chronic Pelvic Pain: Prevalence, Health-Related Quality of Life, and Economic Correlates via openalex
- EAU Guidelines on Chronic Pelvic Pain via openalex
- W2002837765 via openalex
- W2049051142 via openalex
- W2064254036 via openalex
- W2112407242 via openalex
- W2128525590 via openalex
- W2147425799 via openalex
- W2152422815 via openalex
- W2154765924 via openalex
- W2155501711 via openalex
- W2400751176 via openalex
- W2514974009 via openalex
- W2557377110 via openalex
- W2599566629 via openalex
- W2746561549 via openalex
- W2905766599 via openalex
- W2912537816 via openalex
- W2950278175 via openalex
- W3016372696 via openalex
- W3021906178 via openalex
- W3025166166 via openalex
- W3037140548 via openalex
- W3083248748 via openalex
- W3090176419 via openalex
- W3124049150 via openalex
- W3163882233 via openalex
- W4205897567 via openalex
- W4282934219 via openalex
- W4308571592 via openalex
- W1884334763 via openalex
- W6846793786 via openalex
- W1928608880 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK